Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-232-9 | CAS number: 68489-09-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2009-02-02 to 2009-02-25
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- GLP guideline study with minor deviation to the guideline without effects on results: - animals were individually housed - 15 % concentration of hexyl cinnamic aldehyde was used as positive control - preliminary study: erythema was not scored according to the scale stated in the guideline - preliminary study: ear thickness was not taken - identification data of vehicle missing (purity, concentration) - mean and standard deviation of body weight was not calculated
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- , adopted 2002-04-24
- Deviations:
- yes
- Remarks:
- , identification data (purity; volume used) of the vehicle missing
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- , 2008
- Deviations:
- yes
- Remarks:
- , identification data (purity; volume used) of the vehicle missing
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- date of inspection 2008-08-19
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- (1R,2S,5R)-N-(4-methoxyphenyl)-5-methyl-2-(propan-2-yl)cyclohexane-1-carboxamide
- EC Number:
- 700-232-9
- Cas Number:
- 68489-09-8
- Molecular formula:
- C18H27NO2
- IUPAC Name:
- (1R,2S,5R)-N-(4-methoxyphenyl)-5-methyl-2-(propan-2-yl)cyclohexane-1-carboxamide
- Test material form:
- solid: crystalline
- Details on test material:
- - Physical state: solid, whitish to white crystals
- Storage condition of test material: room temperature in the dark
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source:
Harlan Laboratories UK Limited, Bicester, Oxon, UK (CBA/Ca (CBA/CaOlaHsd) strain mice)
B & K Universal Ltd. Hull, UK (CBA/CaBkl strain mice)
- Age at study initiation: eight to twelve weeks old
- Weight at study initiation: preliminary screening test: 18 g; main study: 17 to 21 g
- Housing: individually housed in suspended solid-floor polypropylene cages furnished with softwood woodflakes.
- Diet (ad libitum): 2014 Teklad Global Rodent diet
- Water (ad libitum): mains tap water
- Acclimation period: at least five days
ENVIRONMENTAL CONDITIONS
- Temperature: 19 to 25 °C
- Relative humidity: 30 to 70 %
- Air changes: approximately fifteen changes per hour
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (LLNA)
- Vehicle:
- dimethylformamide
- Concentration:
- 2.5 % w/w, 5 % w/w and 10 % w/w in the vehicle
- No. of animals per dose:
- 4 female mice
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: vehicle was chosen as it produced the highest concentration that was suitable for dosing.
A preliminary screening test was performed using one mouse. The mouse was treated by daily application of 25 µL of the test material at a concentration of 10 % w/w in vehicle, to the dorsal surface of each ear for three consecutive days (Days 1, 2, 3). The mouse was observed twice daily on Days 1, 2 and 3 and once daily on Days 4, 5 and 6. The bodyweight was recorded on Day 1 (prior to dosing) and on Day 6.
Results:
No signs of systemic toxicity were noted.
The dose levels selected for the main test were 10 %, 5 % and 2.5 % w/w in dimethyl formamide.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- groups of four mice were treated with the test material at the three concentrations in the vehicle.
- mice were treated by daily application of 25 µL of the appropriate concentration of the test material to the dorsal surface of each ear for three consecutive days (Days 1, 2, 3).
- a further group of four mice received the vehicle alone in the same manner.
- five days following the first topical application of the test material (Day 6) all mice were injected via the tail vein with 250 µL of phosphate buffered saline (PBS) containing 3H- methyl thymidine (3HTdR: 80 µCi/mL, specific activity 2.0 Ci/mmol) giving a total of 20 µCi to each mouse.
- five hours following the administration of 3HTdR all mice were killed.
- draining auricular lymph nodes from the four mice were excised and pooled for each experimental group.
- 1 mL of PBS was added to the pooled lymph nodes.
- single cell suspension of pooled lymph node cells was prepared by gentle mechanical disaggregation through a 200-mesh stainless steel gauze.
- lymph node cells were rinsed through the gauze with 4 mL of PBS into a petri dish.
- lymph node cell suspension was transferred to a centrifuge tube.
- petri dish was washed with an additional 5 mL of PBS to remove all remaining lymph node cells and these were added to the centrifuge tube.
- pooled lymph node cells were pelleted at 1400 rpm for ten minutes.
- pellet was resuspended in 10 mL of PBS and re-pelleted.
- pellet was resuspended in 3 mL of 5 % Trichloroacetic acid (TCA).
- after approximately eighteen hours incubation at approximately 4 °C, the precipitates were recovered by centrifugation at 2100 rpm for ten minutes, resuspended in 1 mL of TCA and transferred to 10 mL of scintillation fluid.
- 3HTdR incorporation was measured by β-scintillation counting.
- vials containing the samples and scintillation fluid were placed in the sample changer of the scintillator and left for approximately twenty minutes.
- after approximately twenty minutes, the vials were shaken.
- number of radioactive disintegrations per minute was then measured using a scintillation system.
- Criteria used to consider a positive response: the test material was regarded as a sensitiser if at least one concentration of the test material results in a threefold or greater increase in 3HTdR incorporation compared to control values. Any test material failing to produce a threefold or greater increase in 3HTdR incorporation was classified as a "non-sensitiser".
OBSERVATIONS:
- Clinical observations: all animals were observed twice daily on Days 1, 2 and 3 and on a daily basis on Days 4, 5 and 6.
- Bodyweights: bodyweight of each mouse was recorded on Day 1 (prior to dosing ) and Day 6 (prior to termination). - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The proliferation response of lymph node cells was expressed as the number of radioactive disintegrations per minute per lymph node (disintegration per minute/node) and as the ratio of 3HTdR incorporation into lymph node cells of test nodes relative to that recorded for the control nodes (Stimulation index).
Results and discussion
- Positive control results:
- The stimulation index expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle control group are as follows: SI = 4.55
The positive control was considered to be a sensitiser.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: A stimulation index of less than 3 was recorded for all concentrations. 2.5 % w/w: SI = 1.12 5 % w/w: SI = 1.22 10 % w/w: SI = 1.24
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: see Remark
- Remarks:
- Vehicle: 3564.63 (dpm/group); 445.58 (dpm/node) 2.5 % w/w: 4003.20 (dpm/group); 500.40 (dpm/node) 5 % w/w: 4350.42 (dpm/group); 543.80 (dpm/node) 10 % w/w: 4429.53 (dpm per group); 553.69 (dpm/node) dpm/node obtained by dividing the dpm value by 8 (total number of lymph nodes)
Any other information on results incl. tables
OBSERVATIONS:
- clinical observations: there were no deaths and no signs of systemic toxicity.
- bodyweight: changes of the test animals between Day 1 and Day 6 were comparable to those observed in the corresponding control group animals.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The substance is not a skin sensitiser. According to Regulation (EC) No 1272/2008 and subsequent adaptations, the substance does not require classification as skin sensitiser.
- Executive summary:
The skin sensitisation potential of the substance were investigated in female CBA mice using the Local Lymph Node Assay (LLNA) (OECD 429). Based on the results of preliminary testing, concentrations of 2.5, 5, and 10 % of the test item in dimethyl formamide were used in the main test. Groups of four animals were treated with 25 µL per ear of the test item concentrations. A further group of four animals was treated with the vehicle. Historical data were used for the positive control substance (15% α- hexyl cinnamic aldehyde). Treatment was conducted on three consecutive days followed by 3H-methyl thymidine administration on day 6. Five hours following the administration of 3H-methyl thymidine animals were killed and draining auricular lymph nodes from the four mice were excised and pooled for each experimental group. The number of radioactive disintegrations per minute (dpm) was measured using a scintillation system and the Stimulation index was determined for each treatment group.
Overall, any sign of systemic toxicity or mortality was not observed. The body weight changes of the test animals between Day 1 and Day 6 were comparable to those observed in the corresponding control group animals.
Based on the pooled data of cellular proliferation, stimulation indices of 1.12, 1.22, and 1.24 were determined at substance concentrations of 2.5 %, 5 %, and 10 %, respectively. With respect to the derived stimulation index, which is lower than 3, the substance tested not positive for skin sensitisation. The results of the positive control with 15 % α-HCA confirmed the validity of the assay.
According to the Regulation (EC) No 1272/2008 and subsequent adaptations, the test substance is not classified as skin sensitiser.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.